SIRPG and cancer: We would like to point out that targeting SIRPγ with either 2 or 4 μg/mL LSB2.20 could markedly inhibit YAP signaling, cancer sphere formation, and elicit increased phagocytosis (Figure 10A and Supplemental Figure 13, A and D).